7 August 1992 Synergism between photochemical and ionizing radiation effects in MCF-7 cells in vitro
Author Affiliations +
Proceedings Volume 1646, Laser-Tissue Interaction III; (1992) https://doi.org/10.1117/12.137459
Event: OE/LASE '92, 1992, Los Angeles, CA, United States
Both PtCl4 (Rh-123)2 and PtCl4 (Nile Blue)2 interact positively in trimodality therapy including each drug, x-ray, and light (400 - 800 nm) in killing human mammary carcinoma cells (MCF-7) in vitro. The combination treatment results in more than additive killing as assessed by product of the surviving fractions and a significant reduction of the shoulder of the x-ray survival curve. Both of the drugs participate in photodynamic therapy (PDT) in drug and light dose dependent manner. The primary subcellular targets for the neutral platinum complexes were indicated to be the nuclear DNA as opposed to the mitochondria for Rh-123 or the lysosomes for Nile Blue. Because the nuclear DNA is also the primary target for ionizing radiation, drug plus light plus x-ray might cause supraadditive killing. Both PtCl4 (Rh-123)2 and PtCl4 (Nile Blue)2 have been reported to be relatively non-toxic in vivo compared to the anionic or cationic compounds currently being used in photodynamic therapy. Based on these results PtCl4 (Rh-123)2 and PtCl4 (Nile Blue)2 have the potential for use in photodynamic therapy and in trimodality therapy.
© (1992) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Gulshan Ara, Gulshan Ara, Terence S. Herman, Terence S. Herman, Archana Varshney, Archana Varshney, Timothy Korbut, Timothy Korbut, Beverly A. Teicher, Beverly A. Teicher, } "Synergism between photochemical and ionizing radiation effects in MCF-7 cells in vitro", Proc. SPIE 1646, Laser-Tissue Interaction III, (7 August 1992); doi: 10.1117/12.137459; https://doi.org/10.1117/12.137459

Back to Top